AbClon Inc Total Liabilities

Latest as of June 2026: ₩11.43 Billion KRW ≈ $7.75 Million USD

AbClon Inc total liabilities. Based on the latest financial reports, AbClon Inc (174900) has total liabilities worth ₩11.43 Billion KRW (≈ $7.75 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check AbClon Inc (174900) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of AbClon Inc (2015–2025)

Total liabilities of AbClon Inc from 2015 to 2025. This chart illustrates how AbClon Inc's total liabilities have evolved over time, based on quarterly financial data.

AbClon Inc Competitors by Total Liabilities

The table below lists competitors of AbClon Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Suprema Inc KQ:236200	Korea	₩28.79 Billion
Cabaletta Bio Inc NASDAQ:CABA	USA	$46.13 Million
P.C.B Tec TA:PCBT	Israel	ILA76.95 Million
Joyvio Agriculture Development Co Ltd SHE:300268	China	CN¥1.36 Billion
Vimta Labs Limited NSE:VIMTALABS	India	Rs-4.57 Billion
Silver Storm Mining Ltd. V:SVRS	Canada	CA$35.30 Million
Profit Cultural & Creative Group Co Ltd SHE:300640	China	CN¥323.69 Million
Texas Ventures Acquisition III Corp NASDAQ:TVA	USA	$11.86 Million

Liability Composition Analysis (2015–2025)

This chart breaks down AbClon Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see AbClon Inc total assets.

Liquidity & Leverage Metrics

AbClon Inc Total Liabilities Ratios Explained

AbClon Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AbClon Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AbClon Inc (2015–2025)

The table below shows the annual total liabilities of AbClon Inc from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩10.31 Billion ≈ $6.99 Million	-45.10%
2024-12-31	₩18.78 Billion ≈ $12.72 Million	+3.24%
2023-12-31	₩18.19 Billion ≈ $12.33 Million	+4.18%
2022-12-31	₩17.46 Billion ≈ $11.83 Million	+66.76%
2021-12-31	₩10.47 Billion ≈ $7.09 Million	-3.07%
2020-12-31	₩10.80 Billion ≈ $7.32 Million	-6.81%
2019-12-31	₩11.59 Billion ≈ $7.85 Million	+15.84%
2018-12-31	₩10.00 Billion ≈ $6.78 Million	+188.10%
2017-12-31	₩3.47 Billion ≈ $2.35 Million	-13.84%
2016-12-31	₩4.03 Billion ≈ $2.73 Million	+40.95%
2015-12-31	₩2.86 Billion ≈ $1.94 Million	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$240.63 Million

₩355.07 Billion KRW

Market Cap Rank

#15640 Global

#535 in Korea

Share Price

₩17820.00

Change (1 day)

+3.30%

52-Week Range

₩16820.00 - ₩89100.00

All Time High

₩90600.00